Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.39 |
| ▸ | JAK3 | P52333 | 1/20 | 0.39 |
| ▸ | AHR | P35869 | 1/20 | 0.38 |
| ▸ | IDO1 | P14902 | 3/20 | 0.37 |
| ▸ | TDO2 | P48775 | 1/20 | 0.37 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.34 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.33 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.33 |
| ▸ | FBP1 | P09467 | 1/20 | 0.32 |
| ▸ | IKBKB | O14920 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15741510 | 0.79 | CES2 (0.41) | CES2RPS6KA3JAK3AHRIDO1 | |
| SCHEMBL5249757 | 0.78 | CES2 (0.44) | CES2RPS6KA3JAK3AHRIDO1 | |
| SCHEMBL216267 | 0.77 | NFE2L2 (0.55) | CES2IDO1TDO2NFE2L2FBP1 | |
| SCHEMBL440959 | 0.76 | CES2 (0.58) | CES2IDO1ADRB1 | |
| SCHEMBL5543022 | 0.76 | CES2 (0.42) | CES2RPS6KA3JAK3AHRIDO1 | |
| SCHEMBL5776964 | 0.76 | CES2 (0.42) | CES2RPS6KA3JAK3AHRIDO1 | |
| SCHEMBL1547520 | 0.74 | CES2 (0.41) | CES2RPS6KA3JAK3AHRIDO1 | |
| SCHEMBL637115 | 0.74 | CYP1A2 (0.48) | CES2AHRPTGS1FBP1 | |
| SCHEMBL66819 | 0.74 | CES2 (0.46) | CES2RPS6KA3JAK3IDO1TDO2 | |
| SCHEMBL347778 | 0.74 | CES2 (0.41) | CES2RPS6KA3JAK3AHRIDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3277742-A1 | FLUORESCENT SILOXANE ELASTOMER, METHOD FOR PRODUCING SAME, AND USE | Polymerics GmbH (DE) | 2018-02-07 | — | — | EP | claimed |
| WO-2016155695-A1 | FLUORESCENT SILOXANE ELASTOMER, METHOD FOR PRODUCING SAME, AND USE | POLYMERICS GMBH (DE) | 2016-10-06 | — | — | WO | claimed |
| CN-111162312-A | Solid polymer electrolyte containing boron-fluorine structure and preparation method and application thereof | 珠海冠宇电池有限公司 | 2020-05-15 | — | — | CN | disclosed |
| EP-3277742-A1 | FLUORESCENT SILOXANE ELASTOMER, METHOD FOR PRODUCING SAME, AND USE | Polymerics GmbH (DE) | 2018-02-07 | — | — | EP | disclosed |
| WO-2016155695-A1 | FLUORESCENT SILOXANE ELASTOMER, METHOD FOR PRODUCING SAME, AND USE | POLYMERICS GMBH (DE) | 2016-10-06 | — | — | WO | disclosed |
| US-8895565-B2 | Heterocyclic compound and use of the same | NISHIO TETSUYA (JP) | 2014-11-25 | — | — | US | disclosed |
| US-20110319618-A1 | HETEROCYCLIC COMPOUND AND USE OF THE SAME | NISHIO TETSUYA (JP) | 2011-12-29 | — | — | US | disclosed |
| US-20070276011-A1 | Plasminogen Activator Inhibitor-1 Inhibitor | INSTITUTE OF MEDICINAL MOLECULAR DESIGN. INC. (JP) | 2007-11-29 | — | — | US | disclosed |
| EP-1666469-A1 | PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR | Institute of Medicinal Molecular Design, Inc. (JP) | 2006-06-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110319618-A1 | HETEROCYCLIC COMPOUND AND USE OF THE SAME | CYP2D6, CYP2B6, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | CES2 128/4885RPS6KA3 396/4885JAK3 4493/4885 |
| US-20070276011-A1 | Plasminogen Activator Inhibitor-1 Inhibitor | SERPINE1, SERPINC1, SERPINB1 | CES2 4194/4885RPS6KA3 2634/4885JAK3 3030/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.